Diligence memo · auto-generated · as of July 2, 2026
LGM Holdings, LLC
LGM Holdings, LLC looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
LGM Holdings, LLC operates in Pharmaceuticals, based in BOCA RATON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
LGM Holdings, LLC has raised $2.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.0M on 2021-12-23.
Most recent recorded round closed around 2021-12-23.
Valuation (modeled)modeled
Provath models LGM Holdings, LLC at approximately $35M (range $1.5M–$186M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.62× the median modeled value of Seed Pharmaceuticals companies in 2019–2021 (49 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 4.5 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 28% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 36% of those peers.
Closest niche peers: Wiesman Capital & Co., LLC, Curzion Pharmaceuticals, Inc., Providence Therapeutics Inc., EnBiotix, Inc., Metuchen Pharmaceuticals, LLC.
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.